AG˹ٷ

STOCK TITAN

[Form 4] USANA Health Sciences Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

USANA Health Sciences (USNA) � Form 4 filing: Director Gilbert A. Fuller reported the first vesting tranche of a previously granted restricted-stock-unit (RSU) award.

  • Transaction date: 24 Jul 2025
  • Type (Code M): automatic conversion of RSUs into common shares
  • Shares acquired: 1,058 common shares at $0 cost
  • Post-transaction ownership: 1,058 common shares held directly and 3,172 RSUs still outstanding
  • Vesting schedule of remaining RSUs: 25 % on 23 Oct 2025, 22 Jan 2026, and 23 Apr 2026

The filing reflects routine equity-based compensation; no shares were sold and no cash proceeds were involved. The transaction is unlikely to materially affect the company’s share float or signal a directional view beyond normal incentive alignment.

USANA Health Sciences (USNA) � Comunicazione Form 4: Il direttore Gilbert A. Fuller ha riportato la prima tranche di maturazione di un premio in azioni vincolate (RSU) precedentemente assegnato.

  • Data della transazione: 24 luglio 2025
  • Tipo (Codice M): conversione automatica delle RSU in azioni ordinarie
  • Azioni acquisite: 1.058 azioni ordinarie a costo zero
  • Possesso post-transazione: 1.058 azioni ordinarie detenute direttamente e 3.172 RSU ancora in essere
  • Calendario di maturazione delle RSU rimanenti: 25% il 23 ottobre 2025, 22 gennaio 2026 e 23 aprile 2026

La comunicazione riflette una normale compensazione basata su azioni; non sono state vendute azioni né sono stati coinvolti proventi in contanti. La transazione difficilmente influenzerà in modo significativo il flottante azionario della società o indicherà una posizione direzionale oltre il normale allineamento degli incentivi.

USANA Health Sciences (USNA) � Presentación del Formulario 4: El director Gilbert A. Fuller informó sobre el primer tramo de consolidación de una concesión previa de unidades restringidas de acciones (RSU).

  • Fecha de la transacción: 24 de julio de 2025
  • Tipo (Código M): conversión automática de RSU en acciones comunes
  • Acciones adquiridas: 1,058 acciones comunes sin costo
  • Propiedad después de la transacción: 1,058 acciones comunes en propiedad directa y 3,172 RSU aún vigentes
  • Calendario de consolidación de las RSU restantes: 25 % el 23 de octubre de 2025, 22 de enero de 2026 y 23 de abril de 2026

La presentación refleja una compensación rutinaria basada en acciones; no se vendieron acciones ni hubo ingresos en efectivo. Es poco probable que la transacción afecte materialmente el número de acciones en circulación de la empresa o que indique una postura direccional más allá del alineamiento normal de incentivos.

USANA Health Sciences (USNA) � Form 4 신고: 이사 길버� A. 풀러가 이전� 부여된 제한 주식 단위(RSU)� � 번째 권리 확정 분할� 보고했습니다.

  • 거래�: 2025� 7� 24�
  • 유형 (코드 M): RSU� 보통� 자동 전환
  • 취득 주식 �: 비용 없이 1,058� 보통�
  • 거래 � 보유: 직접 보유� 1,058� 보통� � 아직 남아있는 3,172� RSU
  • 남은 RSU 권리 확정 일정: 2025� 10� 23�, 2026� 1� 22�, 2026� 4� 23일에 각각 25%

신고� 일상적인 주식 기반 보상� 반영하며 주식 매도� 현금 수익은 없었습니�. � 거래� 회사� 유통 주식 수에 � 영향� 미치거나 정상적인 인센티브 조정 이상� 방향성을 나타� 가능성� 낮습니다.

USANA Health Sciences (USNA) � Déclaration Formulaire 4 : Le directeur Gilbert A. Fuller a déclaré la première tranche d'acquisition d'une attribution antérieure d'unités d'actions restreintes (RSU).

  • Date de la transaction : 24 juillet 2025
  • Type (Code M) : conversion automatique des RSU en actions ordinaires
  • Actions acquises : 1 058 actions ordinaires à coût nul
  • Possession après la transaction : 1 058 actions ordinaires détenues directement et 3 172 RSU encore en circulation
  • Calendrier d'acquisition des RSU restantes : 25 % le 23 octobre 2025, le 22 janvier 2026 et le 23 avril 2026

Cette déclaration reflète une rémunération habituelle basée sur des actions ; aucune action n'a été vendue et aucun produit en espèces n'a été impliqué. La transaction est peu susceptible d'affecter significativement le flottant de la société ou de signaler une orientation autre que celle de l'alignement normal des incitations.

USANA Health Sciences (USNA) � Form 4 Meldung: Direktor Gilbert A. Fuller meldete die erste Freigabetranche einer zuvor gewährten Restricted Stock Unit (RSU).

  • Transaktionsdatum: 24. Juli 2025
  • Typ (Code M): automatische Umwandlung von RSUs in Stammaktien
  • Erworbene Aktien: 1.058 Stammaktien ohne Kosten
  • Eigentum nach der Transaktion: 1.058 direkt gehaltene Stammaktien und noch 3.172 ausstehende RSUs
  • Vesting-Plan der verbleibenden RSUs: jeweils 25 % am 23. Oktober 2025, 22. Januar 2026 und 23. April 2026

Die Meldung spiegelt eine routinemäßige aktienbasierte Vergütung wider; es wurden keine Aktien verkauft und keine Barauszahlungen getätigt. Die Transaktion wird voraussichtlich keinen wesentlichen Einfluss auf den Streubesitz des Unternehmens haben oder eine richtungsweisende Sicht über die normale Anreizausrichtung hinaus signalisieren.

Positive
  • Director increased direct equity stake by 1,058 shares, modestly aligning insider incentives with shareholders.
Negative
  • None.

Insights

TL;DR: Director merely received 1,058 shares from RSU vesting; no buy/sell, negligible float impact.

The Code M conversion is a non-open-market event and therefore neutral for supply/demand dynamics. Fuller still holds 3,172 unvested RSUs, indicating continued alignment with long-term performance. Absence of share disposal suggests no negative insider sentiment. For a company with ~19 M shares outstanding, 1,058 shares (�0.006 %) have no valuation significance. Overall, the disclosure is routine and non-impactful.

USANA Health Sciences (USNA) � Comunicazione Form 4: Il direttore Gilbert A. Fuller ha riportato la prima tranche di maturazione di un premio in azioni vincolate (RSU) precedentemente assegnato.

  • Data della transazione: 24 luglio 2025
  • Tipo (Codice M): conversione automatica delle RSU in azioni ordinarie
  • Azioni acquisite: 1.058 azioni ordinarie a costo zero
  • Possesso post-transazione: 1.058 azioni ordinarie detenute direttamente e 3.172 RSU ancora in essere
  • Calendario di maturazione delle RSU rimanenti: 25% il 23 ottobre 2025, 22 gennaio 2026 e 23 aprile 2026

La comunicazione riflette una normale compensazione basata su azioni; non sono state vendute azioni né sono stati coinvolti proventi in contanti. La transazione difficilmente influenzerà in modo significativo il flottante azionario della società o indicherà una posizione direzionale oltre il normale allineamento degli incentivi.

USANA Health Sciences (USNA) � Presentación del Formulario 4: El director Gilbert A. Fuller informó sobre el primer tramo de consolidación de una concesión previa de unidades restringidas de acciones (RSU).

  • Fecha de la transacción: 24 de julio de 2025
  • Tipo (Código M): conversión automática de RSU en acciones comunes
  • Acciones adquiridas: 1,058 acciones comunes sin costo
  • Propiedad después de la transacción: 1,058 acciones comunes en propiedad directa y 3,172 RSU aún vigentes
  • Calendario de consolidación de las RSU restantes: 25 % el 23 de octubre de 2025, 22 de enero de 2026 y 23 de abril de 2026

La presentación refleja una compensación rutinaria basada en acciones; no se vendieron acciones ni hubo ingresos en efectivo. Es poco probable que la transacción afecte materialmente el número de acciones en circulación de la empresa o que indique una postura direccional más allá del alineamiento normal de incentivos.

USANA Health Sciences (USNA) � Form 4 신고: 이사 길버� A. 풀러가 이전� 부여된 제한 주식 단위(RSU)� � 번째 권리 확정 분할� 보고했습니다.

  • 거래�: 2025� 7� 24�
  • 유형 (코드 M): RSU� 보통� 자동 전환
  • 취득 주식 �: 비용 없이 1,058� 보통�
  • 거래 � 보유: 직접 보유� 1,058� 보통� � 아직 남아있는 3,172� RSU
  • 남은 RSU 권리 확정 일정: 2025� 10� 23�, 2026� 1� 22�, 2026� 4� 23일에 각각 25%

신고� 일상적인 주식 기반 보상� 반영하며 주식 매도� 현금 수익은 없었습니�. � 거래� 회사� 유통 주식 수에 � 영향� 미치거나 정상적인 인센티브 조정 이상� 방향성을 나타� 가능성� 낮습니다.

USANA Health Sciences (USNA) � Déclaration Formulaire 4 : Le directeur Gilbert A. Fuller a déclaré la première tranche d'acquisition d'une attribution antérieure d'unités d'actions restreintes (RSU).

  • Date de la transaction : 24 juillet 2025
  • Type (Code M) : conversion automatique des RSU en actions ordinaires
  • Actions acquises : 1 058 actions ordinaires à coût nul
  • Possession après la transaction : 1 058 actions ordinaires détenues directement et 3 172 RSU encore en circulation
  • Calendrier d'acquisition des RSU restantes : 25 % le 23 octobre 2025, le 22 janvier 2026 et le 23 avril 2026

Cette déclaration reflète une rémunération habituelle basée sur des actions ; aucune action n'a été vendue et aucun produit en espèces n'a été impliqué. La transaction est peu susceptible d'affecter significativement le flottant de la société ou de signaler une orientation autre que celle de l'alignement normal des incitations.

USANA Health Sciences (USNA) � Form 4 Meldung: Direktor Gilbert A. Fuller meldete die erste Freigabetranche einer zuvor gewährten Restricted Stock Unit (RSU).

  • Transaktionsdatum: 24. Juli 2025
  • Typ (Code M): automatische Umwandlung von RSUs in Stammaktien
  • Erworbene Aktien: 1.058 Stammaktien ohne Kosten
  • Eigentum nach der Transaktion: 1.058 direkt gehaltene Stammaktien und noch 3.172 ausstehende RSUs
  • Vesting-Plan der verbleibenden RSUs: jeweils 25 % am 23. Oktober 2025, 22. Januar 2026 und 23. April 2026

Die Meldung spiegelt eine routinemäßige aktienbasierte Vergütung wider; es wurden keine Aktien verkauft und keine Barauszahlungen getätigt. Die Transaktion wird voraussichtlich keinen wesentlichen Einfluss auf den Streubesitz des Unternehmens haben oder eine richtungsweisende Sicht über die normale Anreizausrichtung hinaus signalisieren.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
FULLER GILBERT A

(Last) (First) (Middle)
3838 WEST PARKWAY BLVD

(Street)
SALT LAKE CITY UT 84120

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/24/2025 M 1,058 A (1) 1,058 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 07/24/2025 M 1,058 (2) (2) Common Stock 1,058 $0 3,172 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Remarks:
/s/ Joshua Foukas, Attorney-in-Fact 07/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many USNA shares did Director Gilbert A. Fuller acquire on 24 July 2025?

1,058 common shares were acquired through RSU conversion.

What does transaction code "M" mean in the USNA Form 4?

Code M indicates the exercise or conversion of derivative securities such as RSUs into common stock.

How many restricted stock units does Fuller still hold after the transaction?

He retains 3,172 unvested RSUs that will vest in three future tranches.

Were any USNA shares sold or dispositions reported in this Form 4?

No. The filing reports only an acquisition of shares; no sales were disclosed.
Usana Health Sciences Inc

NYSE:USNA

USNA Rankings

USNA Latest News

USNA Latest SEC Filings

USNA Stock Data

537.46M
10.76M
42.13%
57.76%
4.28%
Packaged Foods
Medicinal Chemicals & Botanical Products
United States
SALT LAKE CITY